Joseph Ngonzi
ID: UNCST-2019-R001579
|
AI-driven placental imaging tool to reduce adverse pregnancy outcomes through prediction of neonatal sepsis risk: Feasibility of clinical use
REFNo: HS7432ES
To evaluate the feasibility, usability, and acceptability of the RAISE tool for use at delivery. ,
|
Uganda |
2026-05-11 17:48:50 |
2029-05-11 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Crispus Natwijuka
ID: UNCST-2024-R016280
|
TESTING NRIMS VERSION 2
REFNo: SIR662ES
testing testing testing
|
Uganda |
2026-05-06 10:30:12 |
2029-05-06 |
Engineering and Technology |
Clinical Trial |
Non-degree Award |
|
Joseph Babigumira
ID: UNCST-2026-R023369
|
Behavioral Research for Informed Government Decision-Making Using Evidence (BRIDGE Trial)
REFNo: SS5072ES
Primary Objectives
1. To determine the relative effect of narrative framing (with citizen voice) versus technical framing of research evidence on senior policymakers' use of evidence, measured through citations in policy documents, requests for new analyses, and evidence-informed budget allocations.
2. To determine the relative effect of peer civil servant messengers versus external academic expert messengers on senior policymakers' use of research evidence, measured through the same behavioural outcomes.
3. To assess whether framing and messenger mechanisms interact, and which combination produces the greatest improvement across the four evidence-informed policymaking (EIPM) outcome domains: conceptual, attitudinal, procedural, and content.
Secondary Objectives
4. To identify through which cognitive, social, and procedural pathways framing and messenger interventions influence evidence use (e.g., comprehension, trust, integration into decision routines).
5. To assess how treatment effects vary by ministry (Finance, Trade, Energy, NPA), seniority (U1–U2 vs. U3–U4), gender, and baseline orientation to evidence.
6. To estimate the cost-effectiveness of each intervention variant per unit increase in evidence uptake, expressed as cost per 0.1 standard deviation increase in the Evidence Use Index (EUI).
7. To examine how electoral cycles, bureaucratic turnover, and patronage networks moderate the effectiveness of behavioural interventions during Uganda's 2025–2027 reform window.
Exploratory Objective
8. To assess what early signals suggest that increased evidence use contributes to improved economic policy outcomes (e.g., trade facilitation, domestic revenue mobilisation), recognising that attribution is limited within the 24-month trial horizon.
|
Uganda |
2026-04-30 18:43:15 |
2029-04-30 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
PROSSY SENYANGE
ID: UNCST-2025-R020541
|
PREVALENCE AND FACTORS ASSOCIATED WITH HIGH-RISK HPV POSITIVITY FOLLOWING TREATMENT FOR PRECANCEROUS CERVICAL LESIONS AMONG WOMEN LIVING WITH HIV AT MBARARA REGIONAL REFERRAL HOSPITAL.
REFNo: HS7368ES
General objective
To determine the prevalence and factors associated with high risk HPV positivity after treatment for precancerous lesions among women living with HIV at Mbarara Regional Referral Hospital
Specific Objectives
1. To determine the prevalence of high-risk HPV positivity after treatment for precancerous lesions among women living with HIV at Mbarara Regional Referral Hospital.
2. To determine the factors associated with high risk HPV positivity after treatment for precancerous lesions among women living with HIV at MRRH
|
Uganda |
2026-04-30 18:41:23 |
2029-04-30 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
Mercy chelangat
ID: UNCST-2025-R017873
|
PREVALENCE OF HIGH ACUTE GLYCEMIC VARIABILITY, ITS ASSOCIATED FACTORS, AND 14 DAY MORTALITY AMONG PATIENTS ADMITTED WITH SEPSIS AT MBARARA REGIONAL REFERRAL HOSPITAL
REFNo: HS7303ES
General Objective
To determine the prevalence of high acute glycemic variability, its associated factors and 14-day mortality among patients admitted with sepsis at MRRH.
Specific Objectives
1. Determine the prevalence of high acute glycemic variability among patients admitted with sepsis at MRRH
2. To determine the factors associated with high acute glycemic variability among patients admitted with sepsis
3. To compare the 14-day mortality rates between sepsis patients with high versus normal acute glycemic variability
|
Uganda |
2026-04-30 18:40:37 |
2029-04-30 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|